on 02 Dec 2024
Last Applicant/ Owned by
I-20152 Milano
IT
Serial Number
79362396 filed on 26th Jul 2022
Registration Number
N/A
Correspondent Address
David D. Rodrigues
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
Medical diagnostic apparatus for medical purposes for human stool analysis; diagnostic apparatus for medical purposes for human stool analysis; diagnostics, examination and monitoring equipment, namely, in vitro diagnostics, examination and monitoring equipment for helicobacter pylori detection in human samples; apparatus for carrying-out diagnostic tests for medical purposes for helicobacter pylo Read More
Medical diagnostic apparatus for medical purposes for human stool analysis; diagnostic apparatus for medical purposes for human stool analysis; diagnostics, examination and monitoring equipment, namely, in vitro diagnostics, examination and monitoring equipment for helicobacter pylori detection in human samples; apparatus for carrying-out diagnostic tests for medical purposes for helicobacter pylori detection in human samples
N/A
N/A
Reagents for medical purposes; test reagents for medical use; diagnostic preparations for medical purposes; diagnostic preparations for medical or veterinary purposes; diagnostic test reagents for medical purposes; immunodiagnostic reagents for medical purposes; Medical diagnostic kit designed to comprising reagents for immunodiagnostics
N/A
N/A
No 79362396
No Service/Collective Mark
No 9282/015
No
No
No
No
Yes
Yes
No
No
Status Date | Action Taken |
---|---|
18th Dec 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
26th Nov 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
25th Nov 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
25th Nov 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
25th Nov 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
17th Nov 2024 | REFUSAL PROCESSED BY IB |
28th Oct 2024 | REFUSAL PROCESSED BY MPU |
28th Oct 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
26th Oct 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
25th Oct 2024 | NON-FINAL ACTION WRITTEN |